Table 2 Ivermectin treatment by demographic factors
Total Population (N = 3311) | |||||
|---|---|---|---|---|---|
Eligible population/total population (%) | Eligible population for ivermectin (N = 2370) | ||||
No MDA complete (%) | 1 month of MDA complete (%) | 2 months of MDA complete (%) | 3 months of MDA complete (%) | ||
Total | 2730/3311 (82.5) | 484 (17.73) | 327 (11.98) | 512 (18.8) | 1407 (51.5) |
Houshold head MDA | |||||
Complete | 1445/1754 (82.4) | 222 (15.3) | 140 (9.7) | 242 (16.8) | 841 (58.2) |
Incomplete | 816/1006 (81.1) | 149 (18.2) | 131 (16.1) | 186 (22.8) | 350 (42.9) |
None | 469/551 (85.1) | 113 (24.1) | 56 (11.9) | 84 (17.9) | 216 (46.1) |
Age group | |||||
< 5 years | 116/585 (19.8) | 10 (8.6) | 16 (13.8) | 31 (26.7) | 59 (50.9) |
5–15 years | 1010/1065 (94.8) | 35 (3.5) | 70 (6.9) | 177 (17.5) | 728 (72.1) |
>15–25 years | 524/543 (96.5) | 157 (30) | 84 (16) | 110 (21) | 173 (33) |
>25–50 | 742/780 (95.1) | 233 (31.4) | 110 (14.8) | 129 (17.4) | 270 (36.4) |
> 50 years | 338/338 (100) | 49 (14.5) | 47 (13.9) | 65 (19.2) | 177 (52.4) |
Sex | |||||
Female | 1457/1780 (81.9) | 309 (21.2) | 183 (12.6) | 253 (17.4) | 712 (48.9) |
Male | 1273/1531 (83.1) | 175 (13.8) | 144 (11.31) | 259 (20.4) | 695 (54.6) |
Ethnicity | |||||
Fula | 1716/2065 (83.1) | 166 (9.7) | 206 (12) | 353 (20.6) | 991 (57.8) |
Mandinka | 526/638 (82.4) | 54 (10.3) | 44 (8.4) | 89 (16.9) | 339 (64.5) |
Sarahule | 115/134 (85.8) | 8 (6.9) | 9 (7.8) | 23 (20) | 75 (65.2) |
Wollof | 3/3 (100) | 0 (0) | 0 (0) | 1 (33.3) | 2 (66.7) |
Not specified | 370/471 (78.6) | 256 (69.2) | 68 (18.4) | 46 (12.4) | 0 (0) |
Household size | |||||
< 6 | 46/51 (90.2) | 5 (10.9) | 5 (10.9) | 11 (23.9) | 25 (54.4) |
6–11 | 322/391 (82.4) | 57 (17.7) | 55 (17.1) | 61 (18.9) | 149 (46.3) |
12–24 | 1137/1373 (82.8) | 195 (17.2) | 119 (10.5) | 195 (17.2) | 628 (55.2) |
25–50 | 937/1141 (82.1) | 168 (17.9) | 104 (11.1) | 177 (18.9) | 488 (52.1) |
> 50 | 288/355 (81.1) | 59 (20.5) | 44 (15.3) | 68 (23.6) | 117 (40.6) |